NYSE:ZYME

Zymeworks Stock Predictions

Healthcare > Biotechnology

Buy ZYME

*Your capital is at risk

$23.90

+5.38 (+29.05%)

At Close: Nov 17, 2025

Currently predicting for Wed, 19 Nov 2025

Trading levels for ZYME

Full Access. No Commitment. 14 Days Free!

Long & Short-Term Golden Star Lists

AI Stock Analysis*

Top 5 Candidates on Every List

Premium Lists

Ad-FREE Browsing

Advanced Stock Screener

GET STARTED!

Already have an account? Sign In Here

Fibonacci Support & Resistance Levels

Level	Price
R3	27.85	16.53%
R2	26.46	10.72%
R1	25.60	7.13%
Price	23.90
S1	22.83	-4.50%
S2	21.97	-8.09%
S3	20.58	-13.90%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	0	-
R2	0	-
R1	0	-
Price	23.90
S1	19.30	-19.25%
S2	18.47	-22.72%
S3	18.05	-24.48%

ZYME Predictions History

2 weeks ago
quantumenigma777 predicted that ZYME for Oct. 29th is going

Rank:

2 years ago
AlexVel predicted that ZYME for 2023-10-30 is going $6.68 (-4.44%)

2 years ago
PredictionBot.Kathy predicted that ZYME for 2023-10-27 is going $6.78 (2.00%)

2 years ago
PredictionBot.Warren predicted that ZYME for 2023-10-27 is going $6.74 (1.42%)

2 years ago
AlexVel predicted that ZYME for 2023-10-27 is going $6.56 (-1.35%)

2 years ago
AlexVel predicted that ZYME for 2023-08-24 is going $7.84 (2.35%)

2 years ago
AlexVel predicted that ZYME for 2023-08-23 is going $8.01 (0.50%)

2 years ago
PredictionBot.Kathy predicted that ZYME for 2023-04-14 is going $9.87 (-0.60%)

2 years ago
PredictionBot.Warren predicted that ZYME for 2023-04-14 is going $9.95 (0.15%)

2 years ago
nevadacoop predicted that ZYME for 2023-04-14 is going

Rank:

ABOUT ZYMEWORKS INC

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
UNIT $6.00	4.83%	Nov 04
TBPH $14.14	27.58%	Oct 23
A AMIX $1.12	2.68%	Oct 23
COCO $40.85	11.21%	Oct 23
LAUR $29.55	1.20%	Oct 22

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by